American Heart Association Selects Eight Startups for Health Technology Accelerator

The American Heart Association, through its Center for Health Technology and Innovation, has announced the selection of eight startups to join the Heart and Brain Health Accelerator. This program is designed to harness technology to improve patient outcomes, lower healthcare costs, and remove obstacles to care, with a special focus on women's heart and brain health. Lisa Suennen, managing partner of American Heart Association Ventures, highlighted the importance of innovation in combating heart disease and stroke. The accelerator offers these startups mentorship, financial support, and access to a network of experts, aiming to expedite the transition of their technologies from the conceptual stage to practical application.

Selected startups include Kelvin Health, which employs artificial intelligence for non-invasive diagnostics of vascular diseases, and LightHearted AI Health, known for its contactless device that detects heart conditions. MOMM Diagnostics is working on a blood test for early detection of preeclampsia, whereas Powerful Medical specializes in AI-assisted ECG interpretation. The cohort also features Reach Neuro, Sinaptica Therapeutics, SynchNeuro, and Veravas, each contributing groundbreaking solutions ranging from stroke recovery aids to non-invasive Alzheimer's therapy and devices for monitoring blood sugar levels.

These startups will also participate in the MedTech Innovator program, providing them with additional resources and the chance to compete in the MedTech Innovator Competition Finals. The selection process, overseen by a committee of healthcare and technology professionals, underscores the potential of these technologies to significantly impact women's health. This initiative represents a critical step forward in addressing the unique challenges faced by women in heart and brain health, leveraging cutting-edge technology to create more accessible and effective healthcare solutions.